drugset / Trial / NCT02532140
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
RandomizedCrossoverQuadruple-blindBasic science
Summary
• To evaluate the safety,tolerability and pharmacokinetics of single intravenous doses of WCK 5107 alone and in combination with cefepime in healthy adult human subjects.
Timeline
- Start
- 2015-08
- Primary completion
- 2015-11
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cefepime | Small molecule | 2000 mg | Intravenous |
| Subject | Zidebactam | Small molecule | 250 mg | Intravenous |
| Subject | Zidebactam | Small molecule | 1000 mg | Intravenous |
| Subject | Zidebactam | Small molecule | 2000 mg | Intravenous |
Indications
No indication recorded.